Individualized blood management for major non-cardiac surgery
Part of Blood & lymphatic clinical trials.
This trial tests a personalized approach to managing your own blood during surgery, which may reduce the need for donor blood transfusions. It is for people having planned non-cardiac surgery expected to need a large amount of blood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for elective non-cardiac surgery that is expected to require more than 8 units of blood (about 1600 mL)
- You are between 18 and 75 years old
- Your hemoglobin level is above 120 g/L (if you are a man) or above 110 g/L (if you are a woman) before surgery
- You do not refuse blood transfusions
- You do not have serious heart, lung, brain, kidney, or blood disorders
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a personalized plan for when to give blood transfusions works better than the usual approach in people having heart surgery with a heart-lung machine. The goal is to find a safer and more effective way to manage transfusions during recovery.
This trial tests a technique called acute normovolemic hemodilution (ANH) during bone cancer surgery. ANH involves removing some blood before surgery and replacing it with fluids, then giving the blood back after surgery to reduce the need for donor blood transfusions.
This study tests whether personalized blood pressure management during and after major surgery can reduce complications and death in older adults with heart or blood vessel risks. It aims to find the safest blood pressure targets for each patient.
This study looks at how hospitals manage your blood during and after planned surgeries that have a moderate to high risk of bleeding. It aims to find better ways to reduce blood loss and the need for transfusions.
This trial tests a blood management strategy to help people with anemia who are having coronary artery bypass surgery (CABG). If you qualify, you may receive a treatment to improve your blood counts before surgery, which could reduce the need for transfusions.
This trial studies a program to manage blood levels before, during, and after heart surgery. It may help reduce the need for blood transfusions and improve recovery.
Hear when a new Transfusion Related Complication trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.